PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Article in Cell Death & Disease (April 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in Cell Death & Disease (April 2024)
Article in Genome Medicine (April 2024)
Article in Cell Reports (March 2024)